131 related articles for article (PubMed ID: 11265654)
1. American Brachytherapy Society recommendations for clinical implementation of NIST-1999 standards for palladium-103 brachytherapy: in regard to Beyer et al. IJROBP 2000;47:273-275.
Vikram B
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):898-9; author reply 899. PubMed ID: 11265654
[No Abstract] [Full Text] [Related]
2. In regard to the American Brachytherapy Society recommendations for 103palladium brachytherapy. Beyer et al. IJROBP 2000;47:273-275.
King P; Anderson RS
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):899. PubMed ID: 11265655
[No Abstract] [Full Text] [Related]
3. 125 Gy or 135 Gy? Comments on the American Brachytherapy Society article by Beyer et al. IJROBP 2000;47:273-275.
Lee PC; Moran BJ
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):897-8. PubMed ID: 11265653
[No Abstract] [Full Text] [Related]
4. In regard to Beyer, Nath, and Butler et al. IJROBP 2000;47:273-275.
Michalski JM; Williamson JF
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):900. PubMed ID: 11265656
[No Abstract] [Full Text] [Related]
5. Calibration, calculation, and prescription issues in permanent prostate brachytherapy with (103)Pd.
Bice WS; Prestidge BR; Sarosdy MF
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):289-91. PubMed ID: 11163528
[No Abstract] [Full Text] [Related]
6. Regarding Blasko et al. palladium-103 brachytherapy for prostate carcinoma. IJROBP 2000;46:839-850.
Vikram B
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1267. PubMed ID: 11228645
[No Abstract] [Full Text] [Related]
7. American brachytherapy society recommendations for clinical implementation of NIST-1999 standards for (103)palladium brachytherapy. The clinical research committee of the American Brachytherapy Society.
Beyer D; Nath R; Butler W; Merrick G; Blasko J; Nag S; Orton C
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):273-5. PubMed ID: 10802349
[TBL] [Abstract][Full Text] [Related]
8. Regarding, Kubo, Coursey, Hanson et al., IJROBP 1998; 40:697-702.
Nath R; Beyer D; Friedland J; Grimm P; Nag S
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):469-70. PubMed ID: 10928845
[No Abstract] [Full Text] [Related]
9. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy.
Viswanathan AN; Erickson BA; Ibbott GS; Small W; Eifel PJ
Brachytherapy; 2017; 16(1):68-74. PubMed ID: 28109633
[TBL] [Abstract][Full Text] [Related]
10. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103.
Rivard MJ; Butler WM; Devlin PM; Hayes JK; Hearn RA; Lief EP; Meigooni AS; Merrick GS; Williamson JF
Brachytherapy; 2007; 6(1):34-7. PubMed ID: 17284383
[TBL] [Abstract][Full Text] [Related]
11. 103Pd brachytherapy dose prescription.
Wallace RE
Med Phys; 1999 Sep; 26(9):2034-5. PubMed ID: 10505895
[No Abstract] [Full Text] [Related]
12. Regarding, Dattoli, Wallner, Sorace, Koval, Cash, Acosta, Brown, Etheridge, Binder, Brunelle, Kirwan, Sanchez, Stein, and Wasserman IJROBP 35(5):875-879; 1996.
Ben-Josef E; Shamsa F
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):776-7. PubMed ID: 9336164
[No Abstract] [Full Text] [Related]
13. Brachytherapy doses for prostate cancer customized to risk factors: is it more important "how much" or "where"? In regard to Stone et al. (Int J Radiat Oncol Biol Phys 2007;69:1472-1477).
Oton CA; Oton F
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):962; author reply 962-3. PubMed ID: 18514795
[No Abstract] [Full Text] [Related]
14. Transrectal ultrasound-guided interstitial radiation therapy for localized prostate cancer.
Brosman SA; Tokita K
Prog Clin Biol Res; 1991; 370():291-300. PubMed ID: 1924462
[No Abstract] [Full Text] [Related]
15. A method for implementing the American Association of Physicists in Medicine Task Group-43 dosimetry recommendations for 125I transperineal prostate seed implants on commercial treatment planning systems: regarding Luse et al. IJROBP 37:737-741; 1997.
Rustgi SN
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):243. PubMed ID: 10477029
[No Abstract] [Full Text] [Related]
16. American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the transperineal permanent brachytherapy of prostate cancer.
Rosenthal SA; Bittner NH; Beyer DC; Demanes DJ; Goldsmith BJ; Horwitz EM; Ibbott GS; Lee WR; Nag S; Suh WW; Potters L; ;
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):335-41. PubMed ID: 21106306
[TBL] [Abstract][Full Text] [Related]
17. The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma.
Walsh P
J Urol; 2001 Oct; 166(4):1581-2. PubMed ID: 11569476
[No Abstract] [Full Text] [Related]
18. Prostate brachytherapy as monotherapy: Are there gaps, holes, and islands in the argument? In regard to Wallner et al. (Int J Radiat Oncol Biol Phys 2003;57:1297-1303).
Rubenstein J
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):305; author reply 305-6. PubMed ID: 15629630
[No Abstract] [Full Text] [Related]
19. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer.
Nag S; Beyer D; Friedland J; Grimm P; Nath R
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):789-99. PubMed ID: 10386635
[TBL] [Abstract][Full Text] [Related]
20. [The recommendations of the International Commission on Radiological Protection (ICRP) for high-dose-rate brachytherapy and for permanent prostatic implants].
Cosset JM; Pinillos-Ashton L; Mettler F;
Cancer Radiother; 2004 Nov; 8 Suppl 1():S50-5. PubMed ID: 15679247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
